Skip to content

Efficacy of Short Wave and Laser Therapy in Patients With Plantar Fasciitis

Efficacy of Extracorporeal Shock Wave Therapy Versus High-intensity Laser Therapy in Patients With Plantar Fasciitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07672327
Acronym
Blind assessor
Enrollment
60
Registered
2026-06-26
Start date
2026-06-01
Completion date
2026-07-01
Last updated
2026-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plantar Fasciitis, Chronic

Brief summary

Plantar fasciitis is a common painful condition. It accounts for 10-15% of all foot painful conditions. Recently, Extracorporeal shock wave therapy (ESWT) was used as an effective method in treatment of different musculoskeletal disorders. High-intensity laser therapy (HILT) is a relatively recent treatment option that has shown benefits in a wide range of musculoskeletal disorders.

Interventions

OTHERconventional physical therapy

exercise

OTHERExtracorporeal shock wave therapy

ESWT

Sponsors

Ibrahim Abuomar Fadulaalhq Alramadhani
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

3 groups, each group consisted of 20 participants

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* 1\. Patients will be included according to the diagnostic criteria for plantar fasciitis of the American physical therapy association (APTA) (Martin et al., 2014). This criterion includes pain in medial sole and heel of foot: most pronounced in initial steps after a period of inactivity, it also worsens after prolonged weight bearing, pain during palpation and compression of proximal plantar fascia, limited range of motion in active and passive ankle dorsiflexion, positive windlass test. 2\. Patients will be referred from an orthopedic surgeon with confirmed diagnosis of plantar fasciitis (Bidoki et al., 2024). 3\. Patients with chronic plantar fasciitis (Duration of patient's symptoms will be more than three months) (Riaz et al., 2023). 4\. Patients' age will range from 18 to 45 years (Bidoki et al., 2024). 5. Both genders (Riaz et al., 2023). 6. Localized non radiating foot pain with an NPRS more than 5 on the first step in the morning (Riaz et al., 2023).

Exclusion criteria

* Patients will be excluded if they present any of the following criteria 1. History of previous surgery of plantar fasciitis (Riaz et al., 2023). 2. History of previous corticosteroid injections (Bidoki et al., 2024). 3. History of heel pain due to previous trauma or calcaneus stress fracture in the last 3 months (Bidoki et al., 2024). 4. History of previous lumbar spine surgery (Bidoki et al., 2024). 5. History of rheumatologic disease (rheumatoid arthritis, diffuse idiopathic skeletal hyperostosis, systemic lupus erythematosus, gout, Sjogren disease, enthesopathy, etc…) (Bidoki et al., 2024). 6. Pregnancy, pacemaker fitted or bleeding disorders (Bidoki et al., 2024). 7. Wounds, infections or tumors in the treatment area (Bidoki et al., 2024).

Design outcomes

Primary

MeasureTime frameDescription
Hand held dynamometer6 weeksHand held dynamometer is a portable device, characterized as a low-cost and convenience to assess muscle strength in a clinical setting
Ultrasonography6 weeksUltrasonography is a type of medical imaging device that uses high-frequency sound (ultrasound) waves to produce images of internal organs and other tissues such as tendons, muscles, joints, blood vessels, and internal organs, to measure some characteristics
Arabic version of foot function index (FFI-Ar)6 weeksFoot functional index is a self-administered index consisting of 23 items divided into 3 subcategories on the basis of: pain, disability and activity limitation.
Arabic version of numerical pain rating scale (NPRS-Ar)6 weeksThe Numerical Rating Scale is an 11-point (0-10) Scale that measures pain intensity, it is considered a very sensitive pain assessment scale.

Countries

Saudi Arabia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 27, 2026